Clinical & Translational Oncology, Journal Year: 2024, Volume and Issue: unknown
Published: July 6, 2024
Language: Английский
Clinical & Translational Oncology, Journal Year: 2024, Volume and Issue: unknown
Published: July 6, 2024
Language: Английский
Journal of Hematology & Oncology, Journal Year: 2025, Volume and Issue: 18(1)
Published: Jan. 13, 2025
The tumor microenvironment (TME) is integral to cancer progression, impacting metastasis and treatment response. It consists of diverse cell types, extracellular matrix components, signaling molecules that interact promote growth therapeutic resistance. Elucidating the intricate interactions between cells TME crucial in understanding progression challenges. A critical process induced by epithelial-mesenchymal transition (EMT), wherein epithelial acquire mesenchymal traits, which enhance their motility invasiveness progression. By targeting various components TME, novel investigational strategies aim disrupt TME's contribution EMT, thereby improving efficacy, addressing resistance, offering a nuanced approach therapy. This review scrutinizes key players emphasizing avenues therapeutically components. Moreover, article discusses implications for resistance mechanisms highlights current toward modulation along with potential caveats.
Language: Английский
Citations
16International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 483 - 503
Published: Jan. 1, 2025
Abstract: Cancer-associated fibroblasts (CAFs) are a heterogeneous population of non-malignant cells that play crucial role in the tumor microenvironment, increasingly recognized as key contributors to cancer progression, metastasis, and treatment resistance. So, targeting CAFs has always been considered an important part immunotherapy. However, improve efficacy therapy is currently major challenge. Nanomaterials show their unique advantages whole process. At present, nanomaterials have achieved significant accomplishments medical applications, particularly field cancer-targeted therapy, showing enormous potential. It confirmed can not only directly target CAFs, but also interact with microenvironment (TME) immune affect tumorigenesis. As for treatment, could enhance therapeutic effect many ways. Therefore, this review, we first summarized current understanding complex interactions between TME, cells, cells. Next, discussed common modern medicine respective impacts on tumors. Finally, focus application nano drug delivery system therapy. Keywords: cancer-associated fibroblasts, delivery, nanomedicine, immunotherapy
Language: Английский
Citations
3Cancer Nanotechnology, Journal Year: 2025, Volume and Issue: 16(1)
Published: Jan. 17, 2025
Emphasizing the significance of cancer-associated fibroblasts (CAFs), non-malignant yet pivotal players within tumor microenvironment (TME), this review illuminates role inflammatory subtype (iCAF) as catalysts in cancer proliferation, metastasis, and therapeutic resistance. Given their paramount importance, targeting CAFs emerges a robust strategy evolving landscape immunotherapy. Nanomaterials, distinguished by unique features malleability, hold considerable promise biomedicine, especially precision-oriented domain therapy. Their aptitude for modulating immune responses, amplifying drug efficacy through precise delivery, discerningly focusing on cells TME situates nanomaterials formidable tools to transcend boundaries set conventional treatments. This scrutinizes convoluted interplay among CAFs, cells, TME. It further showcases widely utilized management. We underscore potential nanoscale delivery systems directed at underscoring transformative power revolutionizing therapies, enhancing precision, culminating improved patient outcomes.
Language: Английский
Citations
2Molecular Cancer, Journal Year: 2024, Volume and Issue: 23(1)
Published: Nov. 30, 2024
In the realm of cancer research, tumor microenvironment (TME) plays a crucial role in initiation and progression, shaped by complex interactions between cells surrounding non-cancerous cells. Cytokines, as essential immunomodulatory agents, are secreted various cellular constituents within TME, including immune cells, cancer-associated fibroblasts, themselves. These cytokines facilitate intricate communication networks that significantly influence initiation, metastasis, suppression. Pyroptosis contributes to TME remodeling promoting release pro-inflammatory sustaining chronic inflammation, impacting processes such escape angiogenesis. However, challenges remain due interplay among cytokines, pyroptosis, along with dual effects pyroptosis on progression therapy-related complications like cytokine syndrome. Unraveling these complexities could strategies balance inflammatory responses while minimizing tissue damage during therapy. This review delves into crosstalk elucidating their contribution metastasis. By synthesizing emerging therapeutic targets innovative technologies concerning this aims provide novel insights enhance treatment outcomes for patients.
Language: Английский
Citations
9Advances in Cancer Biology - Metastasis, Journal Year: 2025, Volume and Issue: unknown, P. 100136 - 100136
Published: Feb. 1, 2025
Language: Английский
Citations
1Cancer Treatment Reviews, Journal Year: 2024, Volume and Issue: 131, P. 102843 - 102843
Published: Oct. 15, 2024
Language: Английский
Citations
7International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(7), P. 3642 - 3642
Published: March 25, 2024
The tumor microenvironment (TME) plays a critical role in cancerogenesis [...]
Language: Английский
Citations
4Cancers, Journal Year: 2024, Volume and Issue: 17(1), P. 66 - 66
Published: Dec. 29, 2024
Hepatocellular carcinoma (HCC) is a major global health issue characterized by poor prognosis and complex tumor biology. One of the critical components HCC microenvironment (TME) tumor-associated macrophages (TAMs), which play pivotal role in modulating growth, immune evasion, metastasis. Macrophages are divided into two subtypes: pro-inflammatory M1 anti-inflammatory M2, both may exist TME with altered function proportion. The M2 further subdivided four distinct suppressive subsets. TAMs generally counted as M2-like functions that exert significant influence on cancer progression ability tumors to escape surveillance. Their involvement responses via different mechanisms at local systemic levels has made them key target for therapeutic interventions seeking enhance treatment outcomes. How TAMs’ depletion influences primary interest immunotherapies. purpose this review delve recent progress TAM-targeting therapies. We will explore current theories, benefits, challenges associated or inhibition. manuscript concludes future directions potential implications clinical practice.
Language: Английский
Citations
4World Journal of Gastroenterology, Journal Year: 2025, Volume and Issue: 31(10)
Published: Feb. 26, 2025
The tumor microenvironment (TME) plays a critical role in the development and treatment of liver cancer, which ranks sixth incidence third mortality worldwide, according to “Global Cancer Statistics 2022”. Hepatocellular carcinoma (HCC), most common form is heavily influenced by TME, affects growth, invasion, metastasis, response various treatments. Despite advancements surgery, transplantation, targeted therapies, immunotherapy, complexity TME often limits efficacy, especially advanced-stage HCC cases. consists dynamic interaction between cells, immune fibroblasts, blood vessels, signaling molecules, all contribute cancer progression therapy resistance. Assessing essential for designing effective, personalized treatments improving patient outcomes. Recent research highlights value imaging technologies as non-invasive tools evaluate offering new possibilities more therapies better prognosis monitoring patients.
Language: Английский
Citations
0Pathology - Research and Practice, Journal Year: 2025, Volume and Issue: 268, P. 155873 - 155873
Published: Feb. 27, 2025
Language: Английский
Citations
0